September 22, 2016 Bio/Pharma/CRO M&A, Partnerships Product Launch

See. Click. Send. New Cloud-based Ultrasound Solution Enables Instant, Enhanced Collaboration Among Clinicians

Rome – 22 September 2016 – GE Healthcare and Trice Imaging, Inc., a cloud-based medical imaging solutions provider, today announced a commercial partnership to provide a new way for clinicians to connect with their colleagues and patients. This solution – called Tricefy™ – adds cloud-based image sharing, diagnostic collaboration, remote reviewing, archiving and Electronic Health Record... Read more

September 22, 2016 Bio/Pharma/CRO Product Launch

R-Pharm produces biological drugs in Yaroslavl with GE Healthcare's FlexFactory™ manufacturing platform

CHALFONT ST. GILES, UK and YAROSLAVL, RUSSIA – 22 September 2016 –  R-Pharm Group has opened an innovative biopharmaceutical production plant equipped with GE Healthcare’s FlexFactory™ manufacturing platform in Yaroslavl, Russia. R-Pharm’s FlexFactory will support the mass production of biologics and biosimilars focused on treating autoimmune diseases and cancer, and allowing for increased access to these... Read more

September 19, 2016 Cell Analysis Tools Clinical Research/Diagn. Product Launch

CE marked MACS® IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485

BERGISCH GLADBACH, 19. September 2016 – Miltenyi Biotec has expanded its assortment of antibodies with a series of CE marked in vitro-diagnostic medical devices – MACS® IVD Antibodies. They can be used in both clinical flow cytometry and in the quality control of cellular products for translational research. The renowned biotech company from Bergisch Gladbach... Read more

September 19, 2016 Bio/Pharma/CRO Product Launch

GE to invest €150 million in biopharmaceutical manufacturing campus in Cork, Ireland, and establish advanced manufacturing training centre at NIBRT

CORK – 19 September, 2016 – Ireland’s Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor TD, today announced that GE (NYSE:GE) is to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland’s strategic site at Loughbeg, Ringaskiddy, Co. Cork.  GE BioPark Cork, subject to contract and planning approvals,... Read more